Lexapro, Escitalopram News

Australia: Lundbeck V Alphapharm 29 June 2009 Article by Kerin Forstmanis, George Cameron and Emma Nelson In a much anticipated decision the Full Federal Court has upheld the validity of Lundbeck's escitalopram patent for its 20 year term but would not allow an extension of the term.

The Corruption Continues: FDA Approves Antidepressants for Children, Even After Revelations of Bribery >> Posted By onlyonesecret 13 hours, 52 minutes ago in News The FDA has approved Forest Laboratories' antidepressant Lexapro for use in children and adolescents, even as the federal government and 11 states have filed a lawsuit against the company ...

The FDA has approved Forest Laboratories' antidepressant Lexapro for use in children and adolescents, even as the federal government and 11 states have filed a lawsuit against the company for illegally pushing the drug on kids.

Nursingcenter.com Exclusively searches the complete text articles from the 50 leading nursing journals available on NursingCenter, including more than 900 continuing education activities, clinical resources and drug updates contained within this website.

The FDA has approved a supplemental New Drug Application for escitalopram oxalate for the acute and maintenance treatment of major depressive disorder, or MDD, in adolescents aged 12 to 17.

Escitalopram Treatment of Generalized Anxiety Disorder in Older Adults - Reply In Reply: The comments by Ms Schwan and Dr Hallberg highlight measurement and analytic issues in anxiety treatment research.

New antidepressants might be no more effective than the best existing drugs, according to two new systematic reviews that compared 12 commonly used medications.

Treatment with an antidepressant drug significantly improves the mood in pregnant substance-dependent women who also smoke cigarettes, according to preliminary results reported at the 2009 Joint Conference of the Society for Research on Nicotine and Tobacco and SNRT-Europe. The data also suggest that the antidepressant - bupropion -- helps these ...

Preliminary results of a new study suggest that pregnant women who are also substance-dependent and smoke cigarettes may significantly benefit from certain antidepressant drugs.

With more than 30 antidepressants on the market, finding the right one is definitely a process.

Last week The SPC Blog featured news that The Dutch first instance decision in ratiopharm et al v Lundbeck , concerning the validity of Lundbeck's escitalopram patent had been handed down by the Hague District Court, which held all the claims of Lundbeck's escitalopram patent invalid for lack of inventive step.

TREATMENT OF DEPRESSION AND ANXIETY >> Posted By bokbong 23 hours, 56 minutes ago in Health & Fitness Escitalopram is the pure enantiomer of racemic citalopram and is a selective serotonin reuptake inhibitor .

Terkko Abstract The aim of this study was to determine predictors of the response to escitalopram, a selective serotonin re-uptake inhibitor antidepressant and memantine, a non-competitive glutamate NMDA receptor blocker, for the treatment of major depression comorbid with alcohol dependence.

For older adults, anxiety is an increasingly common problem, and new research suggests that cognitive behavior therapy may help them ease their worries more than standard care does.

The Massachussetts General Hospital Center for Women's Mental Health is conducting a new study titled "Escitalopram for the treatment of postpartum depresson". It is a 2-month open label trial of Lexapro for women who have been feeling depressed and anxious since giving birth.

Earlier this month, the Food and Drug Administration approved Lexapro for the acute and maintenance treatment of major depressive disorder in adolescents 12- to 17-years-old. Here's some basic information about the approval from a Forest Laboratories press release : "The approval of Lexapro for the treatment of adolescent depression was supported ...

The editors of the Journal of the American Medical Association may be in hot water for dissing a neuroscientist who criticized them for failing to flag a study author's ties to the manufacturer of a drug he reviewed favorably.

Early this month, yet another story surfaced about allegations of undisclosed conflicts of interest affecting the author of a highly publicized clinical trial.

Main Category: Depression Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 21 Mar 2009 - 2:00 PDT Forest Laboratories, Inc.

The company noted that MDD affects approximately 2 million adolescents in the United States.